Quarterly report pursuant to Section 13 or 15(d)

Transactions Affecting Stockholders' Equity - Schedule of Stock Options Granted (Details)

v3.19.1
Transactions Affecting Stockholders' Equity - Schedule of Stock Options Granted (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Equity [Abstract]  
Number of Shares Options Outstanding - Beginning | shares 2,980
Number of Shares, Forfeited | shares (30)
Number of Shares Options Outstanding - End | shares 2,950
Number of Shares Options Vested and Exercisable | shares 858
Weighted Average Exercise Price Options Outstanding - Beginning | $ / shares $ 1.82
Weighted Average Exercise Price, Forfeited | $ / shares 2.35
Weighted Average Exercise Price Options Outstanding - End | $ / shares 1.87
Weighted Average Exercise Price, Options Vested and Exercisable | $ / shares $ 1.88
Weighted Average Remaining Contractual Life (in Years) - Beginning 4 years 9 months 18 days
Weighted Average Remaining Contractual Life (in Years) - Ending 4 years 2 months 12 days
Weighted Average Remaining Contractual Life (in Years) - Options Vested and Exercisable 3 years 10 months 25 days
Total Intrinsic Value - Beginning | $ $ 3,235
Total Intrinsic Value - Ending | $ 3,396
Total Intrinsic Value, Options Vested and Exercisable | $ $ 1,079